Latest News about BLRX
Recent news which mentions BLRX
BioLineRx Touts Encouraging Data From Therapy Trial For First Line Pancreatic Cancer
September 28, 2023
Tickers
BLRX
From Benzinga
HC Wainwright & Co. Maintains Buy Rating for BioLine Rx: Here's What You Need To Know
September 15, 2023
Tickers
BLRX
From Benzinga
Unity Software To Rally Around 60%? Here Are 10 Other Analyst Forecasts For Friday
September 15, 2023
From Benzinga
Earnings Scheduled For August 30, 2023
August 30, 2023
From Benzinga
3 Cheap Biotech Stocks That Smart Investors Will Snap Up Now
August 07, 2023
From InvestorPlace
3 Smart Penny Stocks with Huge Potential
July 18, 2023
From InvestorPlace
From InvestorPlace
Earnings Scheduled For May 24, 2023
May 24, 2023
From Benzinga
7 High-Potential Penny Stocks in the Biotech Sector
May 04, 2023
From InvestorPlace
The 3 Best Biotech Stocks Under $1 to Buy for April
April 04, 2023
From InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
December 29, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 23, 2022
From Benzinga
From InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
November 21, 2022
From Benzinga
Earnings Scheduled For November 15, 2022
November 15, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
November 11, 2022
From Benzinga
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
November 11, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 10, 2022
From Benzinga
From Benzinga
US Markets Turn Higher As Dow Jumps Over 100 Points
September 19, 2022
From Benzinga
Dow, S&P 500 Drop In Volatile Trading Ahead Of Fed's Rate Decision
September 19, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
September 19, 2022
From Benzinga
Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday's Mid-Day Session
September 19, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 19, 2022
From Benzinga
BioLineRx Secures $40M In Debt Financing To Fund Commercialization Of Stem Cell Mobilization For Blood Cancer
September 15, 2022
Tickers
BLRX
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.